Home » Novartis will nominate Giovanni Caforio to succeed President Joerg Reinhardt

Novartis will nominate Giovanni Caforio to succeed President Joerg Reinhardt

by admin
Novartis will nominate Giovanni Caforio to succeed President Joerg Reinhardt

Novartis has resolved the question of the succession of Joerg Reinhardt as chairman of the board of directors a year in advance and will present the candidacy of Giovanni Caforio at the 2025 general meeting. In office since 2013, Mr. Reinhardt will then have reached the ceiling on the number of mandates.

His successor held the general management until last November and until March this year the presidency of the competitor Bristol Myers Squibb, the pharmaceutical giant said on Tuesday during the presentation of its quarterly results. (AWP)

See also  New Zealand bans Tiktok for MPs from March 31st

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy